CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Bioimpedance monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03164356
NCT03164356N/ACompleted

Portable Bioimpedance Monitoring: Testing a New Diagnostic Interface

University of Washington·interventional·Posted May 23, 2017·Updated May 3, 2023

In Brief

A clinical study evaluating Bioimpedance monitor for Transtibial Amputee. Completed, enrolled 68 participants across 1 site.

Detailed Summary

The purpose of the proposed study is to conduct research on individuals with lower limb amputation, evaluating if residual limb fluid volume data collected using a novel non-invasive device is beneficial towards prosthetic prescription, fit, and comfort as determined by amputee test subjects and practitioners (prosthetists). Participants' residual limb fluid volume will be monitored through bioimpedance analysis both before and after a practitioner-issued modification to the prosthesis as an observational cohort study and then as a blinded randomized control trial in which the data may or may not be shared with the practitioner before the modification is made to the prosthesis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 23, 2017
Enrollment StartNov 9, 2016
Primary CompletionSep 14, 2020
Study CompletionDec 23, 2020
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 9.1 years ago

Interventions

Bioimpedance monitordevice

Participant in aim 1 will be monitored using the bioimpedance monitor. Data obtained from the arm 1 cohort will be used to inform socket modifications made for arm 2 cohort.